Modus Therapeutics Holding AB (publ)
Stockholm Stock Exchange MODTX.ST
Modus Therapeutics Holding AB (publ) Free Cash Flow Yield on January 14, 2025
Modus Therapeutics Holding AB (publ) Free Cash Flow Yield is NA on January 14, 2025, a NA change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.
-
Modus Therapeutics Holding AB (publ) 52-week high Free Cash Flow Yield is NA on January 14, 2025, which is NA below the current Free Cash Flow Yield.
-
Modus Therapeutics Holding AB (publ) 52-week low Free Cash Flow Yield is NA on January 14, 2025, which is NA below the current Free Cash Flow Yield.
-
Modus Therapeutics Holding AB (publ) average Free Cash Flow Yield for the last 52 weeks is NA.
Key data
| Date | Free Cash Flow Yield | Market Value Added (MVA) | Price to Book Ratio (P/B) | Price to Earnings Ratio (P/E) |
|---|
Market news
Loading...
Stockholm Stock Exchange: MODTX.ST
| CEO | Dr. John Öhd M.D., Ph.D. |
| IPO Date | July 22, 2021 |
| Location | Sweden |
| Headquarters | Olof Palmes gata 29 IV |
| Employees | 2 |
| Sector | Health Care |
| Industries | |
Description
Modus Therapeutics Holding AB (publ), a biotechnology company, develops a treatment for sepsis and septic shock in Sweden. Its lead product is Sevuparin, a polysaccharide to treat patients with sepsis and septic shock, which is under Phase Ib clinical study. The company was founded in 2011 and is headquartered in Stockholm, Sweden.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email